What the NHS funds for hair loss, and what it does not

The short answer, and where it stops being short

Two of the three things people ask about are settled nationally and quickly. A hair transplant is "not available on the NHS because it's cosmetic surgery", in the words of the NHS's own page on the procedure, last reviewed on 29 September 2023. The medicines are softer but point the same way: the NHS page on hair loss, reviewed on 24 January 2024, says of the treatments generally that they "are not all available on the NHS, so can be expensive if you have to pay", alongside the reminder that they "do not work for everyone" and "only work for as long as they're used".

The third question — what happens when hair loss follows an accident, a burn, an illness or previous surgery — has no national answer at all, and that is the part of this page worth reading carefully.

Cosmetic, reconstructive, and the line between them

The NHS draws a distinction that decides almost everything. Its guidance on cosmetic procedures states that "Cosmetic surgery is not routinely provided on the NHS", while reconstructive or plastic surgery is a different category: surgery that aims to "repair and reconstruct missing or damaged tissue and skin after an illness, accident or birth defect", and which is often available on the NHS.

The same page lists the exceptions where cosmetic procedures have been funded — breast surgery where there is significant psychological distress, ear correction, nose reshaping where there are breathing problems, male breast reduction for long-standing gynaecomastia causing considerable pain or distress. Hair is not among the examples it gives. Worth noting for anyone relying on that page: it was last reviewed on 17 April 2023 with a next review due on 17 April 2026, a date that has passed.

Pattern hair loss sits on the cosmetic side of that line. Hair loss that is the consequence of a burn, a trauma or an operation can sit on the other side of it — but "can" is doing real work in that sentence, because the decision is not made nationally.

Why your postcode is part of the answer

Funding for procedures at the cosmetic edge is decided by local NHS commissioners working to their own published policies, not by a single national rule. That is why two people with similar histories in different parts of England can receive different answers, and why no website can tell you what yours will be.

What that means practically is that the question has an address: your GP. A GP knows the local policy, knows whether an individual funding request is the route, and can say whether your case is the kind the policy contemplates. It is a five-minute conversation that replaces an afternoon of searching, and it costs nothing.

The thing the NHS does fund, which people skip

Diagnosis. And it matters more than the funding question, because a good deal of hair loss is not pattern baldness at all, and the treatments sold for pattern baldness are not the answer to any of it.

The licence for the general-sale topical makes the point by accident. Regaine for Men Extra Strength tells readers not to use it where there is no family history of hair loss, where the loss is sudden or patchy, where it follows childbirth, or where the cause is unknown. Those four exclusions are, between them, a rough map of the hair loss that needs a doctor rather than a shelf: thyroid problems, iron deficiency, alopecia areata, scarring alopecias, telogen effluvium after an illness, reactions to a medicine.

None of that is diagnosable from a photograph or a symptom checker, and all of it is within the ordinary work of a GP appointment that the NHS pays for. Getting it wrong in the other direction is expensive twice over: money spent on the wrong product, and time lost on a condition where time mattered.

The medicines, and where the NHS position actually bites

The NHS page states that finasteride and minoxidil are the main treatments for male pattern baldness, that minoxidil can also be used to treat female pattern baldness, and that "Women should not use finasteride." What it does not say is that the NHS will pay for them for pattern hair loss, and in practice it does not.

That has one consequence people find counter-intuitive. Because pattern hair loss is not an NHS-funded indication, a GP who agrees a medicine is reasonable will generally be writing a private prescription, which you then pay for at a pharmacy. The consultation was still free; the medicine is not. Which of these medicines holds a UK licence, and what each licence is actually for, is set out in what is licensed for hair loss in the UK, and the routes to a prescription are in getting finasteride in the UK.

What this changes about the money conversation

If you were treating the NHS as a possible route to a transplant, it is not one, and the private figure is the figure: the NHS puts a UK hair transplant at between £1,000 and £30,000. The realistic version of the question is therefore not "will the NHS pay" but "what does this cost me", which is the subject of what a hair transplant costs in the UK.

If you were treating the NHS as irrelevant because it funds nothing here, that is also wrong, and more expensively so. A free appointment that establishes what kind of hair loss this is changes what every subsequent pound buys. It is the only step in the whole sequence that is both free and diagnostic.

Asking properly

Book the appointment about the hair loss, not about the product. Describe the pattern, when it started, how fast, and whether anything else changed — an illness, a new medicine, a birth, a period of weight loss. Ask directly whether anything needs excluding before pattern hair loss is assumed, and ask what the local policy is if your loss followed an injury or an operation.

And keep the two questions apart. Whether something is going on is a medical question with a free answer. Whether to buy a treatment for it is a separate question, and a much easier one once the first has been settled. The wider UK picture — who may operate, which register says so and what recourse exists — is on hair transplants in the UK.